Search Results - "Moulia, Danielle L"
-
1
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States
Published in The New England journal of medicine (29-06-2023)“…In this case–control study based on electronic health record data, 2193 patients with mpox were identified. JYNNEOS vaccine effectiveness was approximately 66%…”
Get full text
Journal Article -
2
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States
Published in Vaccine (20-10-2023)“…To inform Advisory Committee for Immunization Practices (ACIP) COVID-19 vaccine policy decisions, we developed a benefit-risk assessment framework that…”
Get full text
Journal Article -
3
Development of COVID-19 vaccine policy — United States, 2020–2023
Published in Vaccine (28-12-2023)“…COVID-19 vaccines represent a great scientific and public health achievement in the face of overwhelming pressures from a global pandemic, preventing millions…”
Get full text
Journal Article -
4
Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US
Published in PloS one (29-04-2019)“…Although influenza vaccination has been shown to reduce the incidence of major adverse cardiac events (MACE) among those with existing cardiovascular disease…”
Get full text
Journal Article -
5
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022
Published in MMWR. Morbidity and mortality weekly report (11-11-2022)“…Four COVID-19 vaccines are currently approved for primary series vaccination in the United States under a Biologics License Application or authorized under an…”
Get full text
Journal Article Newsletter -
6
Key Elements for Conducting Vaccination Exercises for Pandemic Influenza Preparedness
Published in American journal of public health (1971) (01-09-2018)Get full text
Journal Article -
7
2015 Pandemic Influenza Readiness Assessment Among US Public Health Emergency Preparedness Awardees
Published in American journal of public health (1971) (01-09-2017)“…To assess how US Public Health Emergency Preparedness (PHEP) awardees plan to respond to an influenza pandemic with vaccination. The Centers for Disease…”
Get full text
Journal Article -
8
Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program - United States, December 14, 2020-January 14, 2021
Published in MMWR. Morbidity and mortality weekly report (05-02-2021)“…In December 2020, two COVID-19 vaccines (Pfizer-BioNTech and Moderna) were authorized for emergency use in the United States for the prevention of coronavirus…”
Get full text
Journal Article Newsletter -
9
Readiness to Vaccinate Critical Personnel During an Influenza Pandemic, United States, 2015
Published in American journal of public health (1971) (01-10-2017)“…To assess the readiness to vaccinate critical infrastructure personnel (CIP) involved in managing public works, emergency services, transportation, or any…”
Get full text
Journal Article -
10
Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023
Published in MMWR. Morbidity and mortality weekly report (20-10-2023)“…COVID-19 vaccines protect against severe COVID-19-associated outcomes, including hospitalization and death. As SARS-CoV-2 has evolved, and waning vaccine…”
Get full text
Journal Article Newsletter -
11
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
Published in MMWR. Morbidity and mortality weekly report (13-10-2023)“…Respiratory syncytial virus (RSV) is the leading cause of hospitalization among U.S. infants. Nirsevimab (Bevfortus, Sanofi and AstraZeneca) is recommended to…”
Get full text
Journal Article Newsletter -
12
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
Published in MMWR. Morbidity and mortality weekly report (01-07-2022)“…What is already known about this topic? On June 17, 2022, the Food and Drug Administration granted Emergency Use Authorization for the Moderna and…”
Get full text
Journal Article Newsletter -
13
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023
Published in MMWR. Morbidity and mortality weekly report (16-06-2023)“…Throughout the national public health emergency declared in response to the COVID-19 pandemic, CDC, guided by the Advisory Committee on Immunization Practices…”
Get full text
Journal Article Newsletter -
14
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024
Published in MMWR. Morbidity and mortality weekly report (25-04-2024)“…COVID-19 remains an important public health threat, despite overall decreases in COVID-19-related severe disease since the start of the COVID-19 pandemic…”
Get full text
Journal Article Newsletter -
15
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
Published in MMWR. Morbidity and mortality weekly report (05-08-2022)“…What is already known about this topic? On July 13, 2022, the Food and Drug Administration issued Emergency Use Authorization for the NVX-CoV2373 (Novavax)…”
Get full text
Journal Article Newsletter -
16
Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-2025
Published in MMWR. Morbidity and mortality weekly report (19-09-2024)“…COVID-19 vaccination provides additional protection against severe COVID-19-associated illness and death. Since September 2023, 2023-2024 Formula monovalent…”
Get full text
Journal Article Newsletter -
17
Risk of Clade II Mpox Associated with Intimate and Nonintimate Close Contact Among Men Who Have Sex with Men and Transgender Adults - United States, August 2022-July 2023
Published in MMWR. Morbidity and mortality weekly report (10-10-2024)“…A global outbreak of clade II mpox associated with sexual contact, disproportionately affecting gay, bisexual, and other men who have sex with men (MSM), has…”
Get full text
Journal Article Newsletter -
18
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023
Published in MMWR. Morbidity and mortality weekly report (19-05-2023)“…As of March 31, 2023, more than 30,000 monkeypox (mpox) cases had been reported in the United States in an outbreak that has disproportionately affected gay,…”
Get full text
Journal Article Newsletter